Cite
HARVARD Citation
Kim, S. et al. (2022). Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Lancet. 400 (10357), pp. 1008-1019. [Online].